Diversified Subsidiary Companies Presentation slide image

Diversified Subsidiary Companies Presentation

All Other Operating Segments All Other Operating Segments Description Food Packaging: We conduct our Food Packaging segment through our majority owned subsidiary, Viskase Companies, Inc. (OTCPK:VKSC), a worldwide leader in the production and sale of cellulosic, fibrous and plastic casings for the processed meat and poultry industry Home Fashion: We conduct our Home Fashion segment through our wholly owned subsidiary, West Point Home LLC ("WPH"). WPH is engaged in manufacturing, sourcing, marketing, distributing and selling home fashion consumer products Pharma: We conduct our Pharma segment through our wholly owned subsidiary, Vivus LLC. Vivus is a specialty pharmaceutical company with two approved therapies and two product candidates in active clinical development Other Operating Segments Financial Summary FYE December 31, All Other Operating Segments ($Millions) (1) 2021 2022 2023 Selected Income Statement Data: Highlights and Recent Developments Food Packaging Viskase operates plants in the United States, Mexico, Brazil, France, Italy, Germany, Poland, and the Philippines Steady growth is projected globally for cellulose casings, with more emphasis on South America and Asia Pacific markets Market demand is generally resilient as end products represent a cost-effective and attractive source of protein; however inventory reductions in the channel as supply chains have stabilized have had some impact on short term market demand • Business remains focused on reducing complexity and optimizing product and customer mix, while targeting growth with key customers globally Home Fashion Focusing on core profitable customers and product lines Implemented a more customer-focused organizational structure with the intent of expanding key customer relationships and rebuilding the company's sales backlog Continued strength with institutional customers and growth into new international markets including Africa, Australia, and the Middle East Advancing our sustainability efforts in line with our company and customer values Net sales and other revenue from operations $698 $718 $717 Adjusted EBITDA (2) 62 51 93 Pharma Net income (loss) (13) (38) 4 Adjusted EBITDA attributable to IEP (2) 56 45 87 Focused on continued market share gains and prescription growth in the U.S. for both Qsymia and Pancreaze Net income (loss) attributable to IEP (13) (38) 3 Launching Qsymia into European and Middle East markets, coupled with other global licensing deals for other parts of the globe Segment Balance Sheet Data (3): Total assets Continued development of our pipeline products Equity attributable to IEP $1,010 $534 $990 $951 $546 $548 All Other operating segments include Food Packaging, Home Fashion, and Pharma. Results for each of these separate segments can be found in our Quarterly Reports on Form 10-Q and our Annual Report on Form 10-K filed with the SEC. Refer to Adjusted EBITDA reconciliation in the Appendix. (1) (2) (3) Balance Sheet data as of the end of each respective period. 14
View entire presentation